Schwerk, J.; Kemper, L.; Bussey, K.A.; Lienenklaus, S.; Weiss, S.; Čičin-Šain, L.; Kröger, A.; Kalinke, U.; Collins, C.M.; Speck, S.H.;
et al. Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo. Pathogens 2022, 11, 1554.
https://doi.org/10.3390/pathogens11121554
AMA Style
Schwerk J, Kemper L, Bussey KA, Lienenklaus S, Weiss S, Čičin-Šain L, Kröger A, Kalinke U, Collins CM, Speck SH,
et al. Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo. Pathogens. 2022; 11(12):1554.
https://doi.org/10.3390/pathogens11121554
Chicago/Turabian Style
Schwerk, Johannes, Lucas Kemper, Kendra A. Bussey, Stefan Lienenklaus, Siegfried Weiss, Luka Čičin-Šain, Andrea Kröger, Ulrich Kalinke, Christopher M. Collins, Samuel H. Speck,
and et al. 2022. "Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo" Pathogens 11, no. 12: 1554.
https://doi.org/10.3390/pathogens11121554
APA Style
Schwerk, J., Kemper, L., Bussey, K. A., Lienenklaus, S., Weiss, S., Čičin-Šain, L., Kröger, A., Kalinke, U., Collins, C. M., Speck, S. H., Messerle, M., Wirth, D., Brinkmann, M. M., Hauser, H., & Köster, M.
(2022). Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo. Pathogens, 11(12), 1554.
https://doi.org/10.3390/pathogens11121554